746
Views
1
CrossRef citations to date
0
Altmetric
Articles

The efficacy and safety of secondary focused ultrasound therapy for recurrence of non-neoplastic epithelial disorders of the vulva

&
Pages 1310-1314 | Received 30 May 2022, Accepted 26 Sep 2022, Published online: 06 Oct 2022

References

  • O'Connell TX, Nathan LS, Satmary WA, et al. Non-neoplastic epithelial disorders of the vulva. Am Fam Physician. 2008;77(3):321–326.
  • Melnick LE, Steuer AB, Bieber AK, et al. Lichen sclerosus among women in the United States. Int J Womens Dermatol. 2020;6(4):260–262.
  • Thorstensen KA, Birenbaum DL. Recognition and management of vulvar dermatologic conditions: lichen sclerosus, lichen planus, and lichen simplex chronicus. J Midwifery Womens Health. 2012;57(3):260–275.
  • Li JY, Arkfeld CK, Tymon-Rosario J, et al. An evaluation of prognostic factors, oncologic outcomes, and management for primary and recurrent squamous cell carcinoma of the vulva. J Gynecol Oncol. 2022;33(2):e13.
  • Kohn JR, Connors TM, Chan W, et al. Clinical outcomes and adherence to topical corticosteroid therapy in women with vulvar lichen sclerosus: a retrospective cohort study. J Am Acad Dermatol. 2020;83(4):1104–1109.
  • Lewis FM, Tatnall FM, Velangi SS, et al. British association of dermatologists guidelines for the management of lichen sclerosus. Br J Dermatol. 2018;178(4):839–853.
  • Nic Dhonncha E, O'Connor C, O'Connell G, et al. Adherence to treatment with prescribed topical corticosteroid therapy and potential barriers to adherence among female patients with vulvar lichen sclerosus: a prospective cross-sectional study. Clin Exp Dermatol. 2021;46(4):734–735.
  • Mautz TT, Krapf JM, Goldstein AT. Topical corticosteroids in the treatment of vulvar lichen sclerosus: a review of pharmacokinetics and recommended dosing frequencies. Sex Med Rev. 2022;10(1):42–52.
  • Li L, He S, Jiang J. Comparison of efficacy and safety of high-intensity focused ultrasound at different powers for patients with vulvar lichen simplex chronicus. Int J Hyperthermia. 2021;38(1):781–785.
  • Wu C, Zou M, Xiong Y, et al. Short- and long-term efficacy of focused ultrasound therapy for non-neoplastic epithelial disorders of the vulva. BJOG: Int J Obstet Gy. 2017;124( Suppl 3):87–92.
  • Zhou W, Zhu L, Zhou H, et al. The efficacy of high-intensity, focused ultrasound treatment for non-neoplastic epithelial disorders of the vulva. Cell Mol Biol. 2016;62(4):111–115.
  • Li CZ, Bian DH, Wang L, et al. Short and long-term efficacy of focused ultrasound therapy for vulva dystrophy. Zhonghua Fu Chan Ke Za Zhi. 2007;42(1):9–13.
  • Ye M, Deng X, Mao S, et al. High intensity focused ultrasound treatment for non-neoplastic epithelial disorders of the vulva: Factors affecting effectiveness and recurrence. Int J Hyperthermia. 2015;31(7):771–776.
  • Günthert AR, Limacher A, Beltraminelli H, et al. Efficacy of topical progesterone versus topical clobetasol propionate in patients with vulvar lichen sclerosus - A double-blind randomized phase II pilot study. Eur J Obstet Gynecol Reprod Biol. 2022;272:88–95.
  • Corazza M, Schettini N, Zedde P, et al. Vulvar lichen sclerosus from pathophysiology to therapeutic approaches: Evidence and prospects. Biomedicines. 2021;9(8):950.
  • Li Y, Shi J, Tan W, et al. Prospective observational study of the efficacy of mixed methylene blue compound injection for treatment of vulvar non-neoplastic epithelial disorders. Int J Gynaecol Obstet. 2020;148(2):157–161.
  • Bizoń M, Maślińska D, Sawicki W. Influence of photodynamic therapy on lichen sclerosus with neoplastic background. JCM. 2022;11(4):1100.
  • Zhang L, Lai Y, Wan T, et al. A randomized clinical study of the treatment of white lesions of the vulva with a fractional ultrapulsed CO2 laser. Ann Palliat Med. 2020;9(4):2229–2236.
  • Filippini M, Sozzi J, Farinelli M, et al. Effects of fractional CO(2) laser treatment on patients affected by vulvar lichen sclerosus: a prospective study. Photobiomodul Photomed Laser Surg. 2021;39(12):782–788.
  • Kirtschig G, Cooper S, Aberer W, et al. Evidence-based (S3) guideline on (anogenital) lichen sclerosus. J Eur Acad Dermatol Venereol. 2017;31(2):e81–e83.
  • Borghi A, Corazza M. Novel therapeutic approaches and targets for treatment of vulvar lichen sclerosus. Curr Pharm Biotechnol. 2021;22(1):99–114.
  • Li C, Bian D, Chen W, et al. Focused ultrasound therapy of vulvar dystrophies: a feasibility study. Obstet Gynecol. 2004;104(5 Pt 1):915–921.
  • Ruan L, Xie Z, Wang H, et al. High-intensity focused ultrasound treatment for non-neoplastic epithelial disorders of the vulva. Int J Gynaecol Obstet. 2010;109(2):167–170.